IS6761A - Estrógen viðtakastillar - Google Patents
Estrógen viðtakastillarInfo
- Publication number
- IS6761A IS6761A IS6761A IS6761A IS6761A IS 6761 A IS6761 A IS 6761A IS 6761 A IS6761 A IS 6761A IS 6761 A IS6761 A IS 6761A IS 6761 A IS6761 A IS 6761A
- Authority
- IS
- Iceland
- Prior art keywords
- estrogen receptor
- receptor regulators
- regulators
- estrogen
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24158200P | 2000-10-19 | 2000-10-19 | |
| PCT/US2001/042735 WO2002032377A2 (fr) | 2000-10-19 | 2001-10-15 | Modulateurs de recepteurs d'oestrogenes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS6761A true IS6761A (is) | 2003-03-27 |
Family
ID=22911282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS6761A IS6761A (is) | 2000-10-19 | 2003-03-27 | Estrógen viðtakastillar |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1333827A2 (fr) |
| JP (1) | JP2004511502A (fr) |
| KR (1) | KR20030042020A (fr) |
| CN (1) | CN1469743A (fr) |
| AU (2) | AU3238102A (fr) |
| BG (1) | BG107676A (fr) |
| BR (1) | BR0114689A (fr) |
| CA (1) | CA2424729A1 (fr) |
| EA (1) | EA200300474A1 (fr) |
| EC (1) | ECSP034558A (fr) |
| EE (1) | EE200300153A (fr) |
| HU (1) | HUP0303563A2 (fr) |
| IL (1) | IL154984A0 (fr) |
| IS (1) | IS6761A (fr) |
| MX (1) | MXPA03003485A (fr) |
| NO (1) | NO20031737L (fr) |
| PE (1) | PE20021083A1 (fr) |
| PL (1) | PL361053A1 (fr) |
| SK (1) | SK4772003A3 (fr) |
| WO (1) | WO2002032377A2 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030225132A1 (en) * | 2002-04-11 | 2003-12-04 | Dininno Frank P. | Estrogen receptor modulators |
| PT1501819E (pt) | 2002-04-24 | 2010-11-11 | Merck Sharp & Dohme | Moduladores dos receptores de estrogéneo |
| AU2003292625B2 (en) * | 2002-12-26 | 2008-07-24 | Eisai R & D Management Co., Ltd. | Selective estrogen receptor modulators |
| KR101431279B1 (ko) | 2005-07-29 | 2014-08-20 | 리스버로직스 코퍼레이션 | 복합 질환의 예방 및 치료용 약학적 조성물 및 삽입가능한의료 장치에 의한 이의 전달 |
| WO2007049798A1 (fr) * | 2005-10-27 | 2007-05-03 | Banyu Pharmaceutical Co., Ltd. | Nouveau derive de benzoxathiine |
| MX2009008099A (es) | 2007-02-01 | 2009-12-14 | Resverlogix Corp | Compuestos para la prevencion y tratamiento de enfermedades cardiovasculares. |
| EP2382194B1 (fr) | 2009-01-08 | 2014-03-12 | Resverlogix Corp. | Composés pour la prévention et le traitement de maladies cardiovasculaires |
| WO2010106436A2 (fr) | 2009-03-18 | 2010-09-23 | Resverlogix Corp. | Nouveaux agents anti-inflammatoires |
| SI2421533T1 (sl) | 2009-04-22 | 2019-01-31 | Resverlogix Corp. | Nova protivnetna sredstva |
| CA2800673A1 (fr) | 2010-06-10 | 2011-12-15 | Aragon Pharmaceuticals, Inc. | Modulateur du recepteur oestrogenique et utilisation de ces derniers |
| WO2011159769A2 (fr) | 2010-06-17 | 2011-12-22 | Aragon Pharmaceuticals, Inc. | Modulateurs de récepteur d'œstrogène d'indane et utilisations de ceux-ci |
| DK2773354T3 (da) | 2011-11-01 | 2019-08-05 | Resverlogix Corp | Oralformuleringer med øjeblikkelig frigivelse for substituerede quinazolinoner |
| WO2013090829A1 (fr) | 2011-12-14 | 2013-06-20 | Aragon Pharmaceuticals, Inc. | Modulateurs des récepteurs des œstrogènes et ses utilisations |
| WO2014080291A2 (fr) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Dérivés biaryle servant d'inhibiteurs de bromodomaines |
| WO2014080290A2 (fr) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Amines cycliques servant d'inhibiteurs de bromodomaines |
| CA2895905A1 (fr) | 2012-12-21 | 2014-06-26 | Zenith Epigenetics Corp. | Nouveaux composes heterocycliques en tant qu'inhibiteurs de bromodomaine |
| EP3268007B1 (fr) | 2015-03-13 | 2022-11-09 | Resverlogix Corp. | Compositions et procédés thérapeutiques pour le traitement de maladies associées au complément |
-
2001
- 2001-10-15 CA CA002424729A patent/CA2424729A1/fr not_active Abandoned
- 2001-10-15 KR KR10-2003-7005518A patent/KR20030042020A/ko not_active Application Discontinuation
- 2001-10-15 PL PL01361053A patent/PL361053A1/xx not_active Application Discontinuation
- 2001-10-15 IL IL15498401A patent/IL154984A0/xx unknown
- 2001-10-15 BR BR0114689-0A patent/BR0114689A/pt not_active Application Discontinuation
- 2001-10-15 AU AU3238102A patent/AU3238102A/xx active Pending
- 2001-10-15 SK SK477-2003A patent/SK4772003A3/sk unknown
- 2001-10-15 EA EA200300474A patent/EA200300474A1/ru unknown
- 2001-10-15 JP JP2002535616A patent/JP2004511502A/ja not_active Withdrawn
- 2001-10-15 EE EEP200300153A patent/EE200300153A/xx unknown
- 2001-10-15 HU HU0303563A patent/HUP0303563A2/hu unknown
- 2001-10-15 EP EP01987654A patent/EP1333827A2/fr not_active Withdrawn
- 2001-10-15 AU AU2002232381A patent/AU2002232381B2/en not_active Ceased
- 2001-10-15 WO PCT/US2001/042735 patent/WO2002032377A2/fr not_active Application Discontinuation
- 2001-10-15 MX MXPA03003485A patent/MXPA03003485A/es unknown
- 2001-10-15 CN CNA018176720A patent/CN1469743A/zh active Pending
-
2002
- 2002-04-15 PE PE2002000308A patent/PE20021083A1/es not_active Application Discontinuation
-
2003
- 2003-03-26 BG BG107676A patent/BG107676A/bg unknown
- 2003-03-27 IS IS6761A patent/IS6761A/is unknown
- 2003-04-15 NO NO20031737A patent/NO20031737L/no unknown
- 2003-04-17 EC EC2003004558A patent/ECSP034558A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030042020A (ko) | 2003-05-27 |
| CA2424729A1 (fr) | 2002-04-25 |
| WO2002032377A3 (fr) | 2002-08-22 |
| BR0114689A (pt) | 2003-07-01 |
| EA200300474A1 (ru) | 2003-10-30 |
| BG107676A (bg) | 2003-11-28 |
| AU2002232381B2 (en) | 2004-11-18 |
| WO2002032377A2 (fr) | 2002-04-25 |
| AU3238102A (en) | 2002-04-29 |
| HUP0303563A2 (hu) | 2004-03-01 |
| ECSP034558A (es) | 2003-06-25 |
| EE200300153A (et) | 2003-06-16 |
| EP1333827A2 (fr) | 2003-08-13 |
| JP2004511502A (ja) | 2004-04-15 |
| PE20021083A1 (es) | 2002-12-16 |
| SK4772003A3 (en) | 2003-08-05 |
| NO20031737L (no) | 2003-06-19 |
| PL361053A1 (en) | 2004-09-20 |
| CN1469743A (zh) | 2004-01-21 |
| IL154984A0 (en) | 2003-10-31 |
| NO20031737D0 (no) | 2003-04-15 |
| MXPA03003485A (es) | 2003-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60140155D1 (de) | Ortsabhängige Dienstebereitstellung | |
| DE50100900D1 (de) | Fixierelement | |
| CY2010014I1 (el) | Πυρiδinοamiνες ως ρυθμιστες αγγειογενεσης | |
| MA26878A1 (fr) | Regulateurs de recepteurs d'adenosine | |
| DE50113481D1 (de) | Multifunktions-bedieneinrichtung | |
| DE60125079D1 (de) | Nähezustand basierte Service-Anpassung | |
| DE60108010D1 (de) | Toner | |
| FR2809999B1 (fr) | Mecanisme de reglage | |
| DE60109635D1 (de) | Xyz-positioniereinrichtung | |
| IS6761A (is) | Estrógen viðtakastillar | |
| CY1105361T1 (el) | Τετρακυκλικες ετepοενωσεις σαν ρυθμιστες υποδοχεα οιστρογονου | |
| DE10085449T1 (de) | Fixiervorrichtung | |
| NO20013997L (no) | Reseptoranalyse | |
| DE60113760D1 (de) | Synchronregelungsvorrichtung | |
| DK1268453T3 (da) | Östrogen agonist/antagonist metabolitter | |
| DE60004583D1 (de) | Regler | |
| DE60102861D1 (de) | Toner | |
| DE50110589D1 (de) | Verstell-Vorrichtung | |
| DE60131175D1 (de) | Teilezuführungseinrichtung | |
| NO20021295D0 (no) | Nikotinsyreacetylcholin-reseptor | |
| GB0000474D0 (en) | Receptor | |
| AU1252102A (en) | Receptor | |
| IS6692A (is) | 16alfa-metýl eða etýl setin estrógen | |
| DE60135621D1 (de) | Fixiergerät | |
| DE50106738D1 (de) | Schaltwandler |